Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

A phage display selected 7-mer peptide inhibitor of the Tannerella forsythia metalloprotease-like enzyme Karilysin can be truncated to Ser-Trp-Phe-Pro.

Skottrup PD, Sørensen G, Ksiazek M, Potempa J, Riise E.

PLoS One. 2012;7(10):e48537. doi: 10.1371/journal.pone.0048537. Epub 2012 Oct 31.

2.

Structure of the catalytic domain of the Tannerella forsythia matrix metallopeptidase karilysin in complex with a tetrapeptidic inhibitor.

Guevara T, Ksiazek M, Skottrup PD, Cerdà-Costa N, Trillo-Muyo S, de Diego I, Riise E, Potempa J, Gomis-Rüth FX.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 May 1;69(Pt 5):472-6. doi: 10.1107/S1744309113007392. Epub 2013 Apr 27.

3.

The structure of the catalytic domain of Tannerella forsythia karilysin reveals it is a bacterial xenologue of animal matrix metalloproteinases.

Cerdà-Costa N, Guevara T, Karim AY, Ksiazek M, Nguyen KA, Arolas JL, Potempa J, Gomis-Rüth FX.

Mol Microbiol. 2011 Jan;79(1):119-32. doi: 10.1111/j.1365-2958.2010.07434.x. Epub 2010 Nov 2.

4.

A novel matrix metalloprotease-like enzyme (karilysin) of the periodontal pathogen Tannerella forsythia ATCC 43037.

Karim AY, Kulczycka M, Kantyka T, Dubin G, Jabaiah A, Daugherty PS, Thogersen IB, Enghild JJ, Nguyen KA, Potempa J.

Biol Chem. 2010 Jan;391(1):105-17. doi: 10.1515/BC.2010.009.

5.

A pathogenic trace of Tannerella forsythia - shedding of soluble fully active tumor necrosis factor α from the macrophage surface by karilysin.

Bryzek D, Ksiazek M, Bielecka E, Karim AY, Potempa B, Staniec D, Koziel J, Potempa J.

Mol Oral Microbiol. 2014 Dec;29(6):294-306. doi: 10.1111/omi.12080. Epub 2014 Oct 3.

6.

A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system.

Jusko M, Potempa J, Karim AY, Ksiazek M, Riesbeck K, Garred P, Eick S, Blom AM.

J Immunol. 2012 Mar 1;188(5):2338-49. doi: 10.4049/jimmunol.1101240. Epub 2012 Jan 27.

7.

Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of Tannerella forsythia.

Koziel J, Karim AY, Przybyszewska K, Ksiazek M, Rapala-Kozik M, Nguyen KA, Potempa J.

J Innate Immun. 2010;2(3):288-93. doi: 10.1159/000281881. Epub 2010 Feb 4.

8.

A Metalloproteinase Mirolysin of Tannerella forsythia Inhibits All Pathways of the Complement System.

Jusko M, Potempa J, Mizgalska D, Bielecka E, Ksiazek M, Riesbeck K, Garred P, Eick S, Blom AM.

J Immunol. 2015 Sep 1;195(5):2231-40. doi: 10.4049/jimmunol.1402892. Epub 2015 Jul 24.

9.

New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries.

Houimel M, Mach JP, Corthésy-Theulaz I, Corthésy B, Fisch I.

Eur J Biochem. 1999 Jun;262(3):774-80.

10.

A novel mechanism of latency in matrix metalloproteinases.

López-Pelegrín M, Ksiazek M, Karim AY, Guevara T, Arolas JL, Potempa J, Gomis-Rüth FX.

J Biol Chem. 2015 Feb 20;290(8):4728-40. doi: 10.1074/jbc.M114.605956. Epub 2015 Jan 2.

11.

A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.

Roberge M, Santell L, Dennis MS, Eigenbrot C, Dwyer MA, Lazarus RA.

Biochemistry. 2001 Aug 14;40(32):9522-31.

PMID:
11583151
12.

Peptide analogues of the VanS catalytic center inhibit VanR binding to its cognate promoter.

Ulijasz AT, Kay BK, Weisblum B.

Biochemistry. 2000 Sep 19;39(37):11417-24.

PMID:
10985787
13.

Membrane protein topology determination by proteolysis of maltose binding protein fusions.

Miller KW, Konen PL, Olson J, Ratanavanich KM.

Anal Biochem. 1993 Nov 15;215(1):118-28.

PMID:
8297003
14.

Peptides as inhibitors of the first phosphorylation step of the Streptomyces coelicolor phosphoenolpyruvate: sugar phosphotransferase system.

Doménech R, Martínez-Rodríguez S, Velázquez-Campoy A, Neira JL.

Biochemistry. 2012 Sep 18;51(37):7393-402. doi: 10.1021/bi3010494. Epub 2012 Aug 31.

PMID:
22909257
15.

Landscape phages and their fusion proteins targeted to breast cancer cells.

Fagbohun OA, Bedi D, Grabchenko NI, Deinnocentes PA, Bird RC, Petrenko VA.

Protein Eng Des Sel. 2012 Jun;25(6):271-83. doi: 10.1093/protein/gzs013. Epub 2012 Apr 6.

16.

Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.

Jani M, Tordai H, Trexler M, Bányai L, Patthy L.

Biochimie. 2005 Mar-Apr;87(3-4):385-92.

PMID:
15781326
17.

Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.

Larbanoix L, Burtea C, Ansciaux E, Laurent S, Mahieu I, Vander Elst L, Muller RN.

Peptides. 2011 Jun;32(6):1232-43. doi: 10.1016/j.peptides.2011.04.026. Epub 2011 May 6.

PMID:
21575663
18.

Peptide affinity chromatography media that bind N(pro) fusion proteins under chaotropic conditions.

Hahn R, Seifert M, Greinstetter S, Kanatschnig B, Berger E, Kaar W, Jungbauer A.

J Chromatogr A. 2010 Oct 1;1217(40):6203-13. doi: 10.1016/j.chroma.2010.07.074. Epub 2010 Aug 11.

PMID:
20800233
19.

Soluble mimics of the cytoplasmic face of the human V1-vascular vasopressin receptor bind arrestin2 and calmodulin.

Wu N, Macion-Dazard R, Nithianantham S, Xu Z, Hanson SM, Vishnivetskiy SA, Gurevich VV, Thibonnier M, Shoham M.

Mol Pharmacol. 2006 Jul;70(1):249-58. Epub 2006 Mar 30.

20.

Supplemental Content

Support Center